6505--BTK Inhibitors (Acalabrutinib Tablets 100 MG) Base Year Ordering Period - 6/24/24 - 3/23/25

Award Notice Posted

Solicitation number
36E79724R0007
Agency
Awarded
to Astrazeneca Pharmaceuticals LP
Set-aside
No set-aside

Opportunity facts

Contract number
36E79724D0026 Federal IDV award

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center awarded a contract to ASTRAZENECA PHARMACEUTICALS LP for $913,915,470.00 to provide BTK Inhibitors (Acalabrutinib Tablets 100 MG). The base year ordering period for this contract is from June 24, 2024 to March 23, 2025. The Product Service Code is 6505 and the NAICS Code is 325412.

Notice text

Awarded contract 36E79724D0026 to ASTRAZENECA PHARMACEUTICALS LP for 913915470.00 on 2024-04-24.

Files

File Type Posted
36E79724D0026_1.docx DOCX document

Notice history

Notice Type Posted
This notice Award Award Notice
6505--Bruton Tyrosine Kinase (BTK) Inhibitors (VA-24-00023127) Latest solicitation Solicitation
6505--Bruton Tyrosine Kinase (BTK) Inhibitors (VA-24-00023127) Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors